Change Healthcare Past Earnings Performance
Past criteria checks 0/6
Change Healthcare's earnings have been declining at an average annual rate of -19.7%, while the Healthcare Services industry saw earnings growing at 17.5% annually. Revenues have been growing at an average rate of 76.5% per year.
Key information
-19.7%
Earnings growth rate
-12.7%
EPS growth rate
| Healthcare Services Industry Growth | 7.9% |
| Revenue growth rate | 76.5% |
| Return on equity | -2.3% |
| Net Margin | -2.2% |
| Last Earnings Update | 30 Jun 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Change Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 22 | 3,497 | -77 | 754 | 281 |
| 31 Mar 22 | 3,481 | -57 | 735 | 278 |
| 31 Dec 21 | 3,416 | -78 | 736 | 265 |
| 30 Sep 21 | 3,335 | -51 | 711 | 256 |
| 30 Jun 21 | 3,264 | -57 | 699 | 243 |
| 31 Mar 21 | 3,090 | -112 | 687 | 227 |
| 31 Dec 20 | 2,432 | -966 | 536 | 180 |
| 30 Sep 20 | 1,647 | -917 | 376 | 121 |
| 30 Jun 20 | 891 | -969 | 205 | 67 |
| 31 Mar 20 | 197 | -948 | 40 | 12 |
| 31 Dec 19 | 0 | -84 | 3 | 0 |
| 30 Sep 19 | 0 | -147 | 2 | 0 |
| 30 Jun 19 | 0 | -72 | 1 | 0 |
| 31 Mar 19 | 0 | -52 | 1 | 0 |
| 31 Dec 18 | 0 | -70 | 0 | 0 |
| 30 Sep 18 | 0 | 71 | 0 | 0 |
| 30 Jun 18 | 0 | 67 | 0 | 0 |
| 31 Mar 18 | 0 | 61 | 0 | 0 |
Quality Earnings: 1CB is currently unprofitable.
Growing Profit Margin: 1CB is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1CB is unprofitable, and losses have increased over the past 5 years at a rate of 19.7% per year.
Accelerating Growth: Unable to compare 1CB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 1CB is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (11.6%).
Return on Equity
High ROE: 1CB has a negative Return on Equity (-2.34%), as it is currently unprofitable.